A small-cap share soars 25% on Covid-19 test news. Here’s what I’d do now

Covid-19 tests could generate bundles of cash for companies that make them. But will this small-cap’s shares continue to fly?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young woman wearing face mask while walking in the streets of London

Image source: Getty Images

BATM Advanced Communications (LSE: BVC) isn’t a name that would make me immediately think of biotechnology development. But on Tuesday, the firm told us its “Adaltis subsidiary has launched ELISA Serological Test Kits that diagnose if a patient has had Covid-19 by detecting antibodies against it present in their blood.”

The immediate result was a 28% spike in the share price. At the time of writing, the shares have fallen back to a gain of around 20%. But that’s still a pretty nice morning’s profit.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

Israel-based BATM describes itself as “a leading provider of real-time technologies for networking solutions and medical laboratory systems.” Its shares had already been climbing since the pandemic lockdown started, on the back of other coronavirus-related business.

The announcement of a tie-up with life sciences company Novamed in March, for the development of a kit to detect the Covid-19 virus itself, provided a boost. And April’s $31m order to produce ventilators won’t do the firm’s balance sheet any harm.

Not just Covid-19

Since the pandemic commenced its assault on the UK stock market, BATM shares are up around 60%. But the company isn’t just a one-hit Covid-19 wonder. No, the BATM share price has five-bagged over the past five years.

My Motley Fool colleague Kevin Godbold was extolling the virtues of this “dynamic small-cap” in August 2018. While Sirius Minerals was a growth darling at the time, he’d spotted how much better BATM shares were doing. I’m sure I’m one of many who wish they’d listened to Kevin back then.

But back to this Covid-19 antibody test. The company has already shipped initial orders to several European countries. And it says it’s “now ramping up production for larger quantities to fulfil further orders received from these customers.”

Why I’m cautious

Covid-19 antibody testing is likely to play a key role in the opening up of lockdown conditions. It identifies those who have been infected and have recovered, and may have immunity. But I’m cautious about piling into BATM shares for several reasons.

One is that the degree of immunity developed after an infection is unknown, and there are fears it might not be very strong. Secondly, a number of companies are making Covid-19 antibody tests. And a lot of them aren’t sufficiently accurate to be of any general use.


But my final reason for caution is short-termism. Assuming a Covid-19 vaccine is possible, once one is developed and in widespread use, there’ll be no need for antibody tests. Or for any more emergency supplies of ventilators.

This new test, plus the virus test BATM is working on, might well add handsomely to this year’s profits. And maybe even next year’s. But that could well be the end of it.

I’m not saying don’t buy BATM shares. By all means, get in if you like the look of the company. I just urge any potential investor to base your decision on how you see BATM’s long-term prospects, not just on a short-term Covid-19 boost.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Social media and digital online concept, woman using smartphone
Investing Articles

Apple stock: Buffett is long, Burry is short. What should I do?

Our author thinks about whether following Warren Buffet into Apple stock might be a good addition to his portfolio –…

Read more »

Close-up of British bank notes
Investing Articles

5 ‘no-brainer’ dividend shares to buy today

Is there an easy way to narrow down the list of FTSE 100 dividend shares? I try one approach, with…

Read more »

Close-up of British bank notes
Investing Articles

£5,000 to invest? 2 dividend-paying penny stocks I’d hold to 2030

I think these high-yielding penny stocks could help cushion the impact of high inflation on my returns. Here's why I'd…

Read more »

Renewable energies concept collage
Investing Articles

2 green stocks that I think are no-brainer buys for the future

Jon Smith explains two of his favourite green stocks at the moment, one for growth and the other for income…

Read more »

An airplane on a runway
Investing Articles

The Rolls-Royce Share price may be set for take-off!

After an upbeat Civil Aerospace Investor Day, here's why I think the Rolls-Royce share price could be set for take-off…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

2 beaten-down growth stocks to buy as inflation rises

Despite inflationary pressures and recession concerns, I am looking at some top growth stocks to solidify my portfolio over the…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Is the IAG share price too good to miss at current levels?

Jabran Khan delves deeper into the current state of play with the IAG share price and decides if now is…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

5 of the highest-paying income stocks compared! Which one is best for my portfolio?

Income stocks are certainly in vogue right now amid sky-high inflation. But which of these big dividend payers is the…

Read more »